DE69212879T2 - Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren - Google Patents

Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren

Info

Publication number
DE69212879T2
DE69212879T2 DE69212879T DE69212879T DE69212879T2 DE 69212879 T2 DE69212879 T2 DE 69212879T2 DE 69212879 T DE69212879 T DE 69212879T DE 69212879 T DE69212879 T DE 69212879T DE 69212879 T2 DE69212879 T2 DE 69212879T2
Authority
DE
Germany
Prior art keywords
oral administration
pharmaceutical formulations
gastric juice
bile acids
stable pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69212879T
Other languages
English (en)
Other versions
DE69212879D1 (de
Inventor
Egidio Marchi
Gianfranco Tamagnone
Leone Gabriele Rotini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfa Wasserman SpA
Original Assignee
Alfa Wasserman SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wasserman SpA filed Critical Alfa Wasserman SpA
Publication of DE69212879D1 publication Critical patent/DE69212879D1/de
Application granted granted Critical
Publication of DE69212879T2 publication Critical patent/DE69212879T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69212879T 1991-04-12 1992-04-02 Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren Expired - Fee Related DE69212879T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO910113A IT1245890B (it) 1991-04-12 1991-04-12 Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.

Publications (2)

Publication Number Publication Date
DE69212879D1 DE69212879D1 (de) 1996-09-26
DE69212879T2 true DE69212879T2 (de) 1997-01-23

Family

ID=11337390

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69212879T Expired - Fee Related DE69212879T2 (de) 1991-04-12 1992-04-02 Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren

Country Status (8)

Country Link
US (1) US5380533A (de)
EP (1) EP0509335B1 (de)
JP (1) JP2509045B2 (de)
KR (1) KR970005176B1 (de)
CA (1) CA2065773C (de)
DE (1) DE69212879T2 (de)
ES (1) ES2090395T3 (de)
IT (1) IT1245890B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262172A (en) * 1992-06-19 1993-11-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing buffered bile acids
GB9417524D0 (en) * 1994-08-31 1994-10-19 Cortecs Ltd Pharmaceutical compositions
KR100578669B1 (ko) * 1997-05-29 2006-12-07 동아제약주식회사 우르소데옥시콜린산을함유하는투명연질캅셀
DE29717252U1 (de) * 1997-09-26 1998-02-19 Falk Pharma Gmbh Arzneimittelkit aus einem Budesonid-haltigen und einem Ursodesoxycholsäure-haltigen Arzneimittel zur Behandlung von cholestatischen Lebererkrankungen
US6251428B1 (en) 1998-07-24 2001-06-26 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
US20050158408A1 (en) * 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
US7303768B2 (en) * 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US20020068365A1 (en) * 1998-07-28 2002-06-06 Eric H. Kuhrts Controlled release nitric oxide producing agents
DE19906290A1 (de) * 1999-02-15 2000-08-17 Falk Pharma Gmbh Arzneimittel zur Behandlung bzw. Prävention von Darmkrebs
CA2406930C (en) * 2000-02-04 2011-02-15 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
BR0110208A (pt) * 2000-04-19 2003-01-28 Borody Thomas J Composições e terapias para distúrbios associados com hiperlipidemia
US7166234B1 (en) * 2000-10-26 2007-01-23 Integrated Biomedical Technology, Inc. Dialdehyde assay
KR100368936B1 (ko) * 2000-10-04 2003-01-24 주식회사 대웅 우루소데옥시콜린산을 함유한 환경호르몬 독성의 예방 및치료제
WO2002060415A1 (de) * 2001-01-31 2002-08-08 Röhm GmbH & Co. KG Multipartikuläre arzneiform, enthaltend mindestens zwei unterschiedlich überzogene pelletformen
ITMI20012572A1 (it) * 2001-12-06 2003-06-06 Istituto Biochimico Italiano Microgranuli di acido ursodesossicolico
US7145125B2 (en) * 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
TW200533391A (en) * 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
KR101414810B1 (ko) * 2004-08-30 2014-07-18 주식회사 유스팜인터내셔널 국소 허혈 모델에서의 가용화 ｕｄｃａ의 신경보호 효과
DE602005027727D1 (de) * 2004-10-15 2011-06-09 Seo Hong Yoo Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin
JP2008518935A (ja) * 2004-11-01 2008-06-05 セオ ホン ユー 筋萎縮性側索硬化症の神経退行を減少させるための方法及び組成物
EP2367554A4 (de) 2008-11-26 2020-03-25 Satiogen Pharmaceuticals, Inc. Gallensäurerückflusshemmer zur behandlung von adipositas und diabetes
WO2010062863A2 (en) 2008-11-26 2010-06-03 Satiogen Pharmaceuticals, Inc. Compositions containing satiogens and methods of use
PT2376077T (pt) * 2009-01-12 2017-06-23 Biokier Inc Composição e método para tratamento de diabetes
US9006288B2 (en) 2009-01-12 2015-04-14 Biokier, Inc. Composition and method for treatment of diabetes
US9314444B2 (en) 2009-01-12 2016-04-19 Biokier, Inc. Composition and method for treatment of NASH
BR112012006437A2 (pt) * 2009-09-23 2016-04-19 Biokier Inc composições e métodos para tratamento do diabetes e outros distúrbios
US20110152204A1 (en) * 2009-12-18 2011-06-23 Satiogen Pharmaceuticals, Inc. Treatment of Obesity or Diabetes with Bile Acid Sequestrants
WO2011150286A2 (en) 2010-05-26 2011-12-01 Satiogen Pharmaceuticals,Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
KR102051030B1 (ko) 2011-10-28 2019-12-02 루메나 파마수티컬즈, 인코포레이티드 소아 담즙울체성 간 질환 치료용 담즙산 재순환 억제제
WO2015142178A1 (en) 2014-03-20 2015-09-24 Disphar International B.V. Bile acid composition with enhanced solubility

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2340060A1 (de) * 1973-08-08 1975-02-20 Scherer Gmbh R P Magensaftresistente gelatinekapseln und verfahren zu deren herstellung
FR2358144A1 (fr) * 1976-07-13 1978-02-10 Lipha Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
AT389308B (de) * 1984-12-12 1989-11-27 Medica Pharma Co Ltd Verfahren zur herstellung von neuem haeminarginat bzw. haeminlysinat
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
IT1197038B (it) * 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
IT1212141B (it) * 1987-06-03 1989-11-08 So Ri Far S R L Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare.
YU183988A (en) * 1988-09-30 1990-08-31 Lek Tovarna Farmacevtskih Process for preparing dispersion pills of dihydroergotoxine

Also Published As

Publication number Publication date
EP0509335A1 (de) 1992-10-21
CA2065773A1 (en) 1992-10-13
DE69212879D1 (de) 1996-09-26
KR970005176B1 (ko) 1997-04-14
EP0509335B1 (de) 1996-08-21
KR920019359A (ko) 1992-11-19
JP2509045B2 (ja) 1996-06-19
ES2090395T3 (es) 1996-10-16
ITBO910113A1 (it) 1992-10-12
ITBO910113A0 (it) 1991-04-12
US5380533A (en) 1995-01-10
IT1245890B (it) 1994-10-25
CA2065773C (en) 1999-01-26
JPH0597676A (ja) 1993-04-20

Similar Documents

Publication Publication Date Title
DE69212879T2 (de) Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren
DE69212882D1 (de) Gallensäuresalze enthaltende magenstabile pharmazeutische Zusammensetzung zur oralen Verabreichung
IS3957A (is) Aðferð til framleiðslu á þrýstingsúðasamsetningumtil inntöku lyfja með innöndun
ATE203400T1 (de) Pharmazeutische formulierungen
DK362189D0 (da) Farmaceutisk praeparat til intravenoes indgift
DE69613463T2 (de) Filmbildende pharmazeutische zusammensetzungen zur transdermalen verabreichung
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
DK0515312T3 (da) Farmaceutisk præparat
ATA129892A (de) Pharmazeutische zusammensetzung
DE68900994D1 (de) Diphosphonsaeurederivat enthaltendes arzneimittel zur oralen gabe.
DE4291156T1 (de) Verbesserte pharmazeutische Zusammensetzungen
DK385488A (da) Farmaceutisk praeparat indeholdende somatostatinanaloge
EE03744B1 (et) Valproehapet sisaldavad farmatseutilised mikrokerakesed oraalseks manustamiseks
ITTO920303A0 (it) "composizione farmaceutica antiinfiammatoria"
IT9019112A1 (it) Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
IT1223343B (it) Formulazioni farmaceutiche per somministrazione transdermica
NO951933D0 (no) Farmasöytiske formuleringer av ibuprofen
ATA133288A (de) Pharmazeutische zusammensetzung
ITMI913510A0 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
MX9205454A (es) Composicion farmaceutica para administracion oral al tracto gastrointestinal que comprende calcitonina
IT9021021A0 (it) Composizioni farmaceutiche per la somministrazione orale di irudina
IT1223132B (it) Composizione farmaceutica per somministrazione nasale
ATA264087A (de) Pharmazeutische praeparate zur oralen verabreichung
FI944229A0 (fi) Astyylisalisyylihappoon tai sen suoloihin perustuva puristettu farmaseuttinen annosmuoto oraalista antoa varten ja menetelmä sen valmistamiseksi
ITPD920141A1 (it) Formulazioni farmaceutiche per la somministraziane orale di calcitonina

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee